US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Fluocinonide Ointment USP 0.05%

Reason Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.

Teligent Pharma, Inc. NDC 52565-0040-15 D-0064-2021
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot

VistaPharm, Inc. NDC 66689-008-16 D-0019-2021
Class III · Low risk Terminated

Metformin Hydrochloride Tablets USP

Reason Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.

Legacy Pharmaceutical Packaging LLC NDC 68645-545-59 D-1626-2020
Class III · Low risk Terminated

Cystaran

Reason Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Leadiant Biosciences, Inc. NDC 54482-020-01 D-0034-2021
Class III · Low risk Terminated

Homeopathic Energy Catalyst

Reason Labeling: Product Contains Undeclared API; Incorrect formulation

Grato Holdings, Inc. NDC 43742-0756-1 D-0099-2021
Class III · Low risk Terminated

Nymalize

Reason Subpotent Drug

Arbor Pharmaceuticals Inc. NDC 24338-200-12 D-1625-2020
Class III · Low risk Terminated

Citalopram Oral Solution

Reason Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-1696-40 D-0015-2021
Class III · Low risk Terminated

Nicotine Gum

Reason Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.

P & L Developments, LLC NDC 11822-3328-3 D-0004-2021
Class III · Low risk Terminated

Extra Strength Headache Relief

Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Ultra Seal Corporation D-1513-2020
Class III · Low risk Terminated

Pain Relief Maximum Strength

Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Ultra Seal Corporation D-1512-2020
Class III · Low risk Terminated

Red Cross Oral Pain

Reason Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains "Natural Eugenol Oil" in which it does not.

The Mentholatum Company NDC 10742-8902-1 D-1541-2020
Class III · Low risk Terminated

Clobetasol Propionate Cream

Reason Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

Golden State Medical Supply Inc. NDC 60429-902-15 D-1497-2020
Class III · Low risk Terminated

Leucovorin Calcium Tablets USP

Reason Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.

West-Ward Columbus Inc NDC 0054-4497-10 D-1490-2020
Class III · Low risk Terminated

Clobetasol Propionate Cream USP

Reason Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

Taro Pharmaceuticals U.S.A., Inc. D-1496-2020
Class III · Low risk Terminated

Fosaprepitant for Injection

Reason Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Fresenius Kabi USA, LLC NDC 63323-972-10 D-1391-2020
Class III · Low risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Sun Pharmaceutical Industries INC NDC 57664-783-86 D-1445-2020
Class III · Low risk Terminated

Skin Medica Acne System

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC D-1410-2020
Class III · Low risk Terminated

Skin Medica Acne Treatment Lotion

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC NDC 0023-4965-02 D-1409-2020
Class III · Low risk Terminated

Tecfidera

Reason cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Biogen MA Inc. NDC 64406-006-02 D-1381-2020
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

VistaPharm, Inc. NDC 66689-008-16 D-1378-2020
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

VistaPharm, Inc. NDC 66689-037-50 D-1377-2020
Class III · Low risk Terminated

Famotidine Injection

Reason TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020
Class III · Low risk Terminated

Nabumetone Tablets

Reason Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

American Health Packaging D-1372-2020
Class III · Low risk Terminated

Brimonidine Tartrate Opthalmic Solution 0.2%

Reason Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Somerset Therapeutics LLC NDC 70069-233-01 D-1375-2020